Decision making in de novo Parkinson's disease

Movement Disorders

Volumn 25, Issue 10, 2010, Pages 1432-1436

  Poletti, Michele ^a   Frosini, Daniela ^b   Lucetti, Claudio ^a   Del Dotto, Paolo ^a   Ceravolo, Roberto ^b   Bonuccelli, Ubaldo ^a,b  

^a USL of Viareggio   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Amygdala; De novo Parkinson's disease; Decision making; Dopaminergic therapy; Iowa gambling task

Indexed keywords

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; FEMALE; HUMAN; IOWA GAMBLING TASK; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; TASK PERFORMANCE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; CASE-CONTROL STUDIES; COGNITION DISORDERS; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 77954979671     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23098     Document Type: Article

References (40)

1. Aarsland D, Bronnick K, Larsen JP, et al. Cognitive impairment in incident, untreated Parkinson's disease: the Norwegian ParkWest Study. Neurology 2009;72:1121-1126.
2. Muslimovic D, Post B, Speelman JD, et al. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
3. Rowe JB, Hughes L, Ghosh BCP, et al. Parkinson's disease and dopaminergic therapy: differential effects on movement, reward and cognition. Brain 2008;131:2094-2105.
4. Ardila A (2008). On the evolutionary origins of executive functions. Brain Cogn 2008;68:92-99.
5. Cools R, Barker RA, Sahakian BJ, et al. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003;41:1431-1441.
6. Brand M, Labudda K, Kalbe E, et al. Decision-making impairments in patients with Parkinson's disease. Behav Neurol 2004;15:77-85.
7. Stout JC, Rodawalt WC, Siemers ER. Risky decision making in Huntington disease. J Int Neuropsychol Soc 2001:7:92-101.
8. Czernecki V, Pillon B, Houeto JL, et al. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002;40:2257-2267.
9. Thiel A, Hilker R, Kessler J, et al. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Trans 2003;110:1289-1301.
10. Mimura M, Oeda R, Kawamura M. Impaired decision-making in Parkinson's disease. Parkinsonism Relat Disord 2006;12:169-175.
11. Perretta JG, Pari G, Beninger RJ. Effects of Parkinson Disease on two putative nondeclarative learning tasks: probabilistic classification and gambling. Cogn Behav Neurol 2005;18:185-192.
12. Pagonabarraga J, Garcia-Sanchez C, Llebaria G, et al. Controlled study of decision making and cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1430-1435.
13. Kobayakawa M, Koyama S, Mimura M, et al. Decision making in Parkinson's disease: analysis of behavioral and physiological patterns in the Iowa gambling task. Mov Disord 2008;23:547-552.
14. Ibarretxe-Bilbao N, Junque C, Tolosa E, et al. Neuroanatomical correlates of impaired decision making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009;30:1162-1170.
15. Delazer M, Sinz H, Zamarian L, et al. Decision making under risk and under ambiguity in Parkinson's disease. Neuropsychologia 2009;47:1901-1908.
16. Euteneuer F, Schaefer F, Stuermer R, et al. Dissociation of decision making under ambiguity and decision making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia 2009;47:2882-2890.
17. Bechara A, Damasio AR, Damasio H, et al. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50:7-15.
18. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.
19. Owen AM. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004;10:525-537.
20. Gotham A, Brown R, Marsden C. Levodopa treatment may benefit or impair frontal function in Parkinson's disease. Lancet 1986;2:970-971.
21. Frank MJ, Samanta J, Moustafa AA, et al. Hold your horses: impulsivity, deep brain stimulation and medication in parkinsonism. Science 2007;318:1309-1312.
22. Bechara A, Damasio H, Damasio AR, et al. Different contributions of the human amygdala and the ventromedial prefrontal cortex to decision-making. J Neurosci 1999;19:5473-5481.
23. Braak H, Rub U, Steur J, et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005;64:1404-1410.
24. Delaveau P, Salgado-Pineda P, Micaleff-Roll J, et al. Amygdala activation modulated by levodopa during emotional recognition processing in healthy volunteers: a double-blind, placebo controlled study. J Clin Psychopharmacol 2007;27:692-697.
25. Hugues AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;155:181-184.
26. Fahn S, Elton RL; Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NJ: Macmillan Health Care Information; p 153-164.
27. Folstein MF, Folstein SE, McHugh PR. Mini mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
28. Dubois B, Slachesvsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621-1626.
29. Sheik JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Clinical gerontology. A guide to assessment and intervention. New York: The Haworth Press, 1986; p 165-173.
30. Fossati A, Di Ceglie A, Acquarini E, et al. Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subjects. J Clin Psychol 2001;57:815-828.
31. Bechara A. Iowa gambling task professional manual. Lutz, FL: Psychological Assessment Resources.
32. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990;40:1529-1534.
33. Crone EA, Somsen RJ, Van Beek B, et al. Heart rate and skin conductance analysis of antecendents and consequences of decision making. Psychophysiol 2004;41:531-540.
34. Lehto JE, Elorinne E. Gambling as an executive function task. Appl Neuropsychol 2003;10:234-238.
35. Isella V, Mapelli C, Morielli N, et al. Age related quantitative and qualitative changes in decision making ability. Behav Neurol 2008;19:59-63.
36. Adinoff B, Devous MD, Cooper DB, et al. Resting cerebral regional cerebral blood flow and gambling task performance in cocaine dependent subjects and healthy comparison subjects. Am J Psychiatry 2003;160:1892-1894.
37. Sawamoto N, Piccini P, Hotton G, et al. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 2008;131:1294-1302.
38. Tessitore A, Hariri AR, Fera F, et al. Dopamine modulates the response of human amygdala: a study in Parkinson's disease. J Neurosci 2002;22:9099-9103. (Pubitemid 35379080)
39. Kawamura M, Kobayakawa M. Emotional impairment in Parkinson's disease. Parkinsonism Relat Disord 2009;15:S47-S52.
40. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for -CFT binding with positron emission tomography. Ann Neurol 1999;45:601-610.